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Background: X-chromosome inactivation silences one X chromosome in females to achieve dosage compensation
with the single X chromosome in males. While most genes are silenced on the inactive X chromosome, the gene
for the long non-coding RNA XIST is silenced on the active X chromosome and expressed from the inactive X
chromosome with which the XIST RNA associates, triggering silencing of the chromosome. In mouse, an alternative
Xist promoter, P2 is also the site of YY1 binding, which has been shown to serve as a tether between the Xist RNA
and the DNA of the chromosome. In humans there are many differences from the initial events of mouse Xist
activation, including absence of a functional antisense regulator Tsix, and absence of strictly paternal inactivation in
extraembryonic tissues, prompting us to examine regulatory regions for the human XIST gene.
Results: We demonstrate that the female-specific DNase hypersensitivity site within XIST is specific to the inactive X
chromosome and correlates with transcription from an internal P2 promoter. P2 is located within a CpG island that
is differentially methylated between males and females and overlaps conserved YY1 binding sites that are only
bound on the inactive X chromosome where the sites are unmethylated. However, YY1 binding is insufficient to
drive P2 expression or establish the DHS, which may require a development-specific factor. Furthermore, reduction
of YY1 reduces XIST transcription in addition to causing delocalization of XIST.
Conclusions: The differentially methylated DNase hypersensitive site within XIST marks the location of an
alternative promoter, P2, that generates a transcript of unknown function as it lacks the A repeats that are critical
for silencing. In addition, this region binds YY1 on the unmethylated inactive X chromosome, and depletion of YY1
untethers the XIST RNA as well as decreasing transcription of XIST.
Keywords: XIST, X-chromosome inactivation, Alternative promoter, YY1, DNA methylation, Long non-coding RNA,
RNA FISH, DNase hypersensitivity siteBackground
X-chromosome inactivation (XCI) is a process in mam-
malian females allowing for dosage compensation of
X-linked genes between the sexes [1]. XCI is controlled by
an alternatively spliced, long non-coding RNA called
XIST/Xist [2,3] that is up-regulated at the onset of XCI
and is necessary for silencing [4-6]. XIST/Xist coats the fu-
ture inactive X chromosome (Xi) [7] and recruits chroma-
tin modifications that enable transcriptional silencing of
the majority of genes on the Xi. Therefore, to achieve* Correspondence: Carolyn.Brown@ubc.ca
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unless otherwise stated.XCI, a female cell must ensure monoallelic up-regulation
of XIST/Xist while a male cell must fully repress XIST/Xist
expression.
XIST/Xist regulation is dependent on promoter activity
but very little is known about the mechanisms controlling
XIST/Xist promoter action beyond the minimal promoter
sequences required for transcription [8,9]. An alternative
promoter for mouse Xist called P2 has been observed and
is located ~1500 bp downstream of the canonical pro-
moter (P1) [10]. In humans, a region homologous to P2,
in combination with P1, showed higher expression of a re-
porter gene relative to clones containing P1 alone, provid-
ing indirect evidence for conservation of P2 activity [11].
In both mice and humans this region is contained withinral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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tain XIST repression [12]. Demethylation of this island is
correlated with reactivation of XIST in human [13] and
mouse [14] somatic cells. Moreover, the transcription
factor YY1 has recently been shown to be central to the
cis specificity of Xist by tethering Xist RNA to the Xist
genomic locus at binding sites located within the Xist
CpG island [15].
Beyond the XIST/Xist promoter, the minimal region
required for XCI, the X-inactivation centre, (XIC) [16,17],
is believed to contain the regulatory elements essential for
proper regulation of XIST/Xist. An invaluable tool in
understanding Xist regulation has been mouse embryonic
stem (ES) cells due to their ability to undergo XCI during
cellular differentiation [18]. Studies in mouse ES cells have
revealed a network of activating or repressing factors that
are either contained within the Xic or act through the Xic.
Importantly, a non-coding RNA antisense to Xist, called
Tsix, has been proven to be a crucial repressor of Xist
during cellular differentiation, blocking Xist on the Xa and
becoming downregulated on the Xi to allow Xist expres-
sion [19,20]. Several other regulatory factors also act at
the XIC, including CTCF, which represses Xist upregula-
tion [21,22], and RNF12 [23] and the non-coding RNAs
Jpx [22,24] and Ftx [25], which activate Xist expression.
In humans, ES cells show considerable variation
between lines and culture conditions in terms of their
XCI status [26-28]. The variability in human ES cells has
hindered studies of XIST regulation but several lines of
evidence suggest that human and mouse XIST/Xist
regulation may be different. The initial XCI in mouse is
paternally imprinted, with extraembryonic tissues main-
taining inactivation of the paternal X. In humans, XCI is
random in all tissues with respect to the X chromosome
that undergoes inactivation, and the timing of the ini-
tiation and role of any parental imprint has not been
resolved ([29] and reviewed in [30]). Thus the extent to
which the molecular machinery detailed for the initial
choice of X to inactivate in mice is functional in other
species remains to be determined. TSIX/Tsix has under-
gone substantial divergence between species [31,32]. In
the limited human cells reported to transcribe TSIX, the
antisense RNA is not capable of repressing XIST nor
does transcription extend across the XIST promoter
[32], a property crucial to Tsix repression of Xist in
mouse [33], and fluorescent in situ hybridization (FISH)
of TSIX transcripts indicates transcription is originat-
ing from the Xi rather than the Xa [34]. In addition
to differences in TSIX/Tsix, the entire XIC/Xic is
poorly conserved, suggesting that cis-regulatory elements
between species may be rapidly evolving [30,31], and Xist/
XIST appears to be specific to eutheria with a different
long non-coding RNA, Rsx, sharing similar properties in
marsupials [35].DNase I hypersensitivity (DHS) is commonly used to
identify regulatory elements due to their open chromatin
structure being sensitive to digestion by DNase I. Within
the XIC, DHS mapping has revealed three putative re-
gulatory elements, one downstream of XIST and two
upstream of XIST, that do not appear to be conserved
between humans and mice [36]. In this paper we investi-
gate a strong DHS site located within the human XIST
CpG island and find that hypersensitivity correlates with
P2 promoter usage and is independent of YY1 binding.
Results
DNase Hypersensitivity Site (DHS) mapping
To locate candidate cis-regulatory elements for XIST we
surveyed the XIC for DHS sites identified by genome-
wide DHS-seq studies. Interestingly, the strongest DHS
sites within the XIC are located within the XIST CpG
island, ~1.4 kb downstream of the XIST promoter, and are
female-specific. We carried out a DNase I hypersensitivity
assay at two regions, DHS 200b.1, which lies within the
CpG island, and DHS 200a.1 which lies 518 bp down-
stream of the CpG island (Figure 1A). DHS 200b.1 was
hypersensitive to digestion by increasing concentrations of
DNase I in female lymphoblast cells but not in male
lymphoblast cells, while DHS 200a.1 was not hypersensi-
tive in female or male lymphoblast cells (Figure 1B). The
difference between male and female sensitivity at DHS
200b.1 hinted at an Xi to Xa difference so we used Xi and
Xa-containing mouse-human hybrid cells to assess the
chromatin of the Xa and Xi separately. We saw a signifi-
cant increase in sensitivity at DHS 200b.1 in an Xi-
containing mouse-human hybrid cell line and modest
sensitivity at DHS 200a.1, while no effect of DNase treat-
ment was seen at either region in an Xa hybrid cell line
(Figure 1B) which demonstrated that the DHS site was
specific to the Xi. The difference in sensitivity at region
DHS 200a.1 between female lymphoblast cells and Xi-
containing mouse-human hybrid cells is likely a reflection
of the Xa in female cells masking weak sensitivity in the
region. Interestingly, HT-1080 male fibrosarcoma cells
transfected with a DOX inducible XIST cDNA clone
(HT1080XISTi) [37] showed no hypersensitivity before or
after DOX induction of the full-length XIST transcript at
either DHS 200b.1 or DHS 200a.1 (Figure 1C). This may
mean that establishment of the hypersensitivity within the
CpG island of XIST occurs developmentally and is not
recapitulated in differentiated somatic cells.
Promoter Activity of DHS 200b.1
Genome-wide ChIP-seq data on the UCSC genome brow-
ser shows peaks for several promoter-associated proteins
and chromatin modifications in female cell lines overlap-
ping the XIST CpG island and DHS 200b.1. These marks
include RNA Polymerase II, H3K4me3, H3K27ac, H3K9ac
Figure 1 Xi-specific DNase I hypersensitive site ~1.5 kb within XIST. A) Schematic indicating DHS sites from ENCODE genome-wide survey
with locations of primers used for qPCR-based DHS assay. Shading of bars reflects increasing amounts (0, 10, 20 or 40 U) of DNase. B) qPCR-
based DHS assay on female and male lymphoblasts, Xi and Xa mouse-human hybrids and an HT1080 (male fibrosarcoma) cell line containing a
DOX-inducible XIST transgene (HT1080XISTi). Sensitivity of biological triplicates ± standard deviation is shown relative to an unsensitive region. JPX
is used as a positive control. *p = 0.05-0.01, **p = 0.01-0.001, ***p < 0.001, n.s. = not significant.
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YY1, a protein implicated in regulation of XCI in mouse
[21]. Moreover, chromatin state segmentation studies
identify the DHS 200b.1 region as an active promoter [39]
(Figure 2A) and studies in mouse have suggested the
presence of an alternative promoter approximately 1.5 kb
within the Xist gene [10]. To address the question of
promoter activity for DHS 200b.1 we performed 5′ RapidAmplification of cDNA Ends (RACE) assays on a region
overlapping the hypersensitive site and the CpG island
of XIST (Figure 2A). 5′ RACE uncovered three transcrip-
tion start sites (TSS) in the sense orientation spanning a
region of 404 bp across the CpG island (black arrows in
Figure 2A). We therefore conclude that there is an alter-
native promoter of human XIST that we designate as P2.
In the antisense orientation a TSS located at the 3′ edge
Figure 2 Xi-specific DHS site correlates with an actively transcribing P2 promoter. A) Schematic of XIST exon 1 indicating the locations of
primers used for qRT-PCR analysis. The outlined boxes are UCSC tracks showing chromatin state segmentation as determined by compiled ChIP-seq
data (upper) and RNA-seq data for the region (lower) [38,39]. B) Sequenced 5‘RACE products with arrows indicating transcription orientation. C) Levels
of XIST upstream and downstream of P2 determined by qRT-PCR (shown as biological triplicates ± standard deviation). D) Strand-specific qRT-PCR of
P2as transcripts relative to sense XIST (average of biological triplicates ± standard deviation).
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P2as (Figure 2B). Using qPCR primers across XIST exon 1
no significant increase in transcription was found down-
stream of P2, which is corroborated by RNA-seq data in
female cells [38], suggesting that P2 is unlikely to be the
dominant XIST promoter (Figure 2C). Similarly, using
strand-specific qRT-PCR we found P2as transcripts tobe at levels 0.001% of sense XIST transcripts, redu-
cing the likelihood of these having a regulatory function
(Figure 2D). Since XCI and the bulk of XIST regulation
must occur early in human development we also exam-
ined the male human ES cell line CA1S for P2 or P2as
function, which allows for examination of negative re-
gulators of XIST and avoids the variable XCI patterns
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Figure 3 YY1 binding to region of P2 promoter is Xi-specific and
upregulates P1 transcription. A) Chromatin immunoprecipitation
(ChIP) of YY1 binding to P2 shown relative to input, at P2, a negative
control region within XIST, and a positive control region (HCFC1 gene
promoter) for female (IMR-90), HT1080XISTi transgenic XIST, and Xi and
Xa-containing hybrids. A representative ChIP is shown ± standard
deviation of q-PCR triplicates; with replicate experiments showing the
same pattern but variable levels of IP relative to input. B) Q-PCR
following 72 h of siRNA mediated knockdown of YY1 in IMR-90 female
cells demonstrates a decrease in expression of XIST, both upstream
(19, 18) and downstream of P2 (200d.2, qXIST5) relative to cells with a
control (EGFP) knockdown. Levels of YY1 dropped to less than 20%
confirming successful knockdown. C) FISH for XIST RNA following YY1
knockdown. Left panel shows representative IMR-90 female cells
treated with lipofectamine alone (Lipo) and right panel shows cells
after YY1 knockdown. Arrows indicate location of XIST RNA signal
(green) which was substantially reduced after YY1 knockdown.
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the whole gene body of XIST and between 8683 bp to
9934 bp beyond the 3′ end of XIST (Additional file 1:
Figure S1A,B). Strand-specific RT-PCR assays determined
that transcription is in antisense orientation, providing the
first evidence for antisense transcription reaching the
XIST promoter in humans (Additional file 1: Figure S1C).
The faint RT-PCR bands, however, suggested low-level
transcription, which was verified by qRT-PCR, indicating
that the antisense transcript in this region is at 0.00012%
of XIST expression levels in a somatic female lymphoblast.
The region between as well as 5′ of these two primers
contains an enrichment of endogenous retrovirus in the
antisense orientation and an Alu element so it is possible
that transcription is initiating from an endogenous retro-
viral long terminal repeat promoter.
YY1 binding at the P2 region
We next asked whether P2 activity and hypersensitivity at
DHS 200b.1 was correlated with binding of YY1 in vivo
using chromatin immunoprecipitation (ChIP). YY1 was
found to be enriched at P2 in both female cells and Xi-
containing hybrid cells but not Xa-containing hybrid cells,
indicating Xi-specific binding (Figure 3A). We also found
YY1 binding at P2 in inducible XIST HT1080XISTi cells
before induction by DOX, despite these cells lacking a
DHS, demonstrating that YY1 binding is insufficient to
establish hypersensitivity in the P2 region. Since YY1
binding appeared to be independent of the DHS asso-
ciated with P2 we wished to address the impact of
down-regulating YY1 on the transcription of XIST. After
72 h of siRNA-mediated knockdown of YY1 in IMR90
female cells we saw a 50% decrease in expression of XIST,
both upstream and downstream of P2, suggesting that
YY1 may be a regulator of transcription at P1 (Figure 3B).
By fluorescent in situ hybridization for the XIST RNA we
observed only a small focus of expression in 41/86 (48%)
of cells and no detectable signal in 35/86 (40%) of cells,
with substantial delocalization of the RNA in the
remaining 12% of cells (Figure 3C).
DNA Methylation at P2 CpG island
As diagrammed in Figure 2, the region around P2 is
classified as a CpG island according to the more relaxed
‘intermediate’ classification that requires GC content
greater than 50% and an observed CpG frequency to
expected CpG frequency of greater than 0.48 over at least
200 bp [40]. The region 5′ to the CpG island has been
previously reported to be differentially methylated by
restriction enzyme analysis [12] and both the region
immediately upstream of the XIST major promoter (P1 –
two sites) and three sites within the P2 island (see Figure 4)
are present on the Illumina 450 K bead chip and show
intermediate methylation in females and hypermethylationin males [41]. To more completely assess the methylation
across this region, including across the differentially































Figure 4 DNA methylation of the CpG island containing XIST P2. Schematic of the 5′ end of XIST showing P1 and P2 with the intervening
5′ A repeats. Methylation levels shown for each site are the average of two male cell lines, three female cell lines, two Xa and four Xi-containing
hybrids, and the HT1080 with XIST transgenic line. Shown below is the location of the pyrosequencing assays (A to D) designed to assess methylation
at 18 of the 23 CpG sites in the intermediate density CpG island. Also shown are the YY1 sites (based on consensus sequence 5′-CCGCCATNTT-3′ from
http://www.uniprot.org/uniprot/P25490) as well as the CpGs analysed by Illumina 450 K Bead Chip.
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shown in Figure 4. In general, male samples or Xa-
containing hybrids showed over 60% methylation,
while the Xi-containing hybrid had low methylation (see
also Table 1). Females, and also the HT1080XISTi
male cell line with a single copy XIST transgene, showed
intermediate methylation.
Discussion
DHS sites serve as a molecular mark to identify impor-
tant regulatory elements, and a strong DHS within the
human XIST gene has been shown to be female-specific
[42], suggesting an important regulatory role in X in-
activation. Human ES cells have not provided as tract-
able a model for the study of human XIST regulation as
mouse ES cells have been for the study of the earlyTable 1 Activities observed at XIST P2 region
DHS@ +P2 activity ++YY1 binding +++DNA
methylation
Male - - - 78%
Female + + + 44%
Xa Hybrid - -# - 83%
Xi Hybrid + +* + 7%
HT1080XISTi - - + 39%
Male hES -** - -** 80%**
@DHS: DNase Hypersensitive Site (from Figure 1; except for male hES (**)
from UCSC).
+P2 activity from RACE in Figure 2 or #[2]. *band observed with RACE, but
not sequence-confirmed.
++YY1 binding from Figure 3, except ** from UCSC.
+++DNA methylation is an average from 18 sites as shown in Figure 4.events of XCI in mouse. Therefore, we have assessed the
role of the regulatory region demarcated by the DHS site
through correlation of features in a variety of model cell
types, as summarized in Table 1. The female-specificity of
the DHS can be attributed to the presence of an Xi, as
shown by the analysis of the somatic cell hybrids. The
chromatin marks for this region suggest the presence of
promoter activity, and we verified that ′P2′ is the origin
for a variety of transcripts. Presence of the DHS was com-
pletely concordant with P2 promoter activity; however, in
mouse, the P2 region has also been shown to be the site of
binding of YY1. Therefore we assessed YY1 binding by
ChIP and confirm that YY1 binds to the human P2
region. YY1 binds the transgenic XIST, which was inte-
grated in somatic cells, and therefore YY1 binding does
not require passage of the DNA through development.
Furthermore, in these HT1080-derived transgenic cells,
no evidence for P2 transcriptional activity is observed
([37], data not shown), separating P2 function from
YY1 binding. Therefore, P2 function is completely
concordant with the DHS presence, and may require
additional factors, that are perhaps acquired develop-
mentally, for establishment. While the DHS within the
XIST island is the only female-specific site near the XIC
regulatory region, two other female-specific DHS sites
were reported on the human X chromosome, and all were
associated with long non-coding RNA loci [42]. The other
two sites, FIRRE (LOC286467; [43]) and the noncoding
RNA LOC550643 are also affiliated with complex tandem
repeats, differential methylation and CTCF binding, rem-
iniscent of the DXZ4 region [44].
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body of XIST/Xist, and in both cases, transcription from
this promoter would generate a transcript lacking the 5′
A repeats that are critical for the silencing function of
XIST/Xist [37,45], raising the question of whether P2
transcription might be secondary to another function for
the region. The first alternative role we considered was
the generation of other transcripts. All transcription in
the region was only observed from the active XIST/Xist
gene on the Xi, unlike some short RNAs that are tran-
scribed from repressed polycomb target genes or im-
printed loci [46]. In mice, there is a 1.6 kb transcript,
called RepA, that is expressed from the active locus, and
thus the future Xi; however, as the name suggests, this
transcript contains the A repeats [47]. We did identify
an antisense transcript; however, the very low abundance
suggests that this transcript is also not functional;
although higher levels of such an antisense might inter-
fere with P1 transcription, and therefore the sense P2
transcript may be involved in preventing P2 antisense
transcription from silencing functional P1 transcription.
Interestingly, we also observe an antisense transcript
across XIST in human ES cells; however, again, this
transcript is at such low levels it seems unlikely to
reflect a biologically relevant function.
If generation of biologically active transcripts is not
the principal role of this region, transcription in the
region might be an indirect outcome of YY1 binding to
tether the RNA as YY1 binding has recently been shown
to act as a ‘tether’ for the Xist RNA to bind to the DNA
of the chromosome. YY1 binding in the region is seen to
be female-specific in browser tracks, and we confirmed
that this YY1 binding is Xi-specific as it is observed in
Xi, but not Xa-containing hybrids. Interestingly, in these
somatic cell hybrids, despite binding of YY1, the RNA is
not tethered to the chromosome, and drifts away [48],
implicating further species-specific factors in the ability
of DNA to interact with the cis-transcribed RNA. We
also observed YY1 binding in HT1080XISTi transgenic
cells; however, these cells fail to demonstrate P2 activity,
suggesting that P2 transcription is not simply a function
of YY1 binding. To determine if YY1 binding impacted
localization or transcription of XIST we knocked down
YY1 with siRNA. Interestingly, we did observe a reduc-
tion in XIST RNA abundance, across the gene, upon
knock-down of YY1. This could reflect a role for YY1 in
transcription from P1. An alternative explanation could
be that delocalized XIST is more rapidly degraded; how-
ever, in the mouse/human somatic cell hybrids the delo-
calized XIST still had a half-life equivalent to localized
XIST [48]. There could also be downstream effects due
to the knockdown of the important YY1 protein that
have an indirect effect on XIST transcription; however,
reporter assays have shown that inclusion of this regionaugments transcription [11], supporting an enhancer
action for this region.
The binding of YY1 was seen to be concordant with
lack of methylation of the CpG island within XIST. This
region is normally differentially methylated in females,
and differentially methylated regions (DMRs) are often
associated with mono-allelic expression, similar to that
observed for XIST, and also imprinted genes. Such DMRs
often overlap binding regions for the insulator/enhancer
blocking factor CTCF [49], and there is CTCF binding
downstream of the XIST DMR and upstream of P1; how-
ever, neither is sex-specific [41] suggesting that they are
not primary regulators of XIST expression. While binding
of YY1 to the imprinted Peg3 gene was suggested to be
methylation-sensitive [50], the binding of YY1 to DXZ4 is
similarly restricted to the hypomethylated allele, however
binding in vitro is not blocked by DNA methylation [51].
Thus, while YY1 binding is concordant with hypomethyla-
tion, it is not clear wehther DNA methylation prevents
YY1 binding to the Xa. Genome-wide analyses have
shown many additional transcription factors binding the
P2 DMR region, some combination of which likely
contributes to activation of P2 transcription and establish-
ment of the DHS, possibly during early development.
Conclusions
We report an Xi-specific DHS site within the human XIST
locus. This site overlaps a weak CpG island that shows
differential methylation between the Xa and Xi. This
methylation spans five consensus YY1 binding sites, and,
consistent with ENCODE data, YY1 binds in a female-
specific manner. The DHS is concordant with P2 pro-
moter activity; however, transcription from the conserved
P2 results in a transcript of unknown function that lacks
the A repeats previously shown to be critical for silencing.
In addition to P2 activity, this region apparently functions
as both an enhancer and RNA tether, as knockdown of
YY1 reduces P1 transcription and also results in loss of
XIST localization to the Xi.
Methods
DNase I hypersensitivity
2,000,000 cells were harvested and lysed using 0.1% NP40
in resuspension buffer (RSB) (10 mM Tris pH 7.4, 10 mM
NaCl, 3 mM MgCl2). Nuclei were resuspended in RSB
and digested with 0U, 10U, 20U or 40U of DNase I for
10 min at 37°C. Digestion was stopped and DNA was ex-
tracted using 0.8 mL of DNAzol (Invitrogen) followed by
ethanol precipitation. The DNA was diluted to a final
concentration of 20 ng/μl, to be used in qPCR. Primers
for qPCR were designed to span the test hypersensitive
site (200b.1 and 200a.1) as well as a positive control
region (JPX) and an insensitive region (XIST3′5′). Hyper-
sensitivity was calculated by normalizing each DNase I
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from each DNase I concentration were plotted as a fold
difference from the untreated sample.
Tissue culture and cell lines
Mouse-human somatic cell hybrid cell lines, t75-2maz
34-1a (containing a human Xi) and t60-12 (containing a
human Xa) [52] were cultured at 37°C in alpha Mini-
mum Essential Medium (MEM) supplemented with 7.5%
fetal calf serum (PAA Laboratories Inc), 1% penicillin/
streptomycin (Life Technologies) and 1% L-glutamine
(Life Technologies). The GM11200 and GM7057 male
lymphoblast cell lines and GM11201, and GM7350
female lymphoblast cells lines (Coriell cell repository)
were maintained in Roswell Park Memorial Institute
(RPMI) medium supplemented with 15% fetal calf serum
(PAA Laboratories Inc), 1% penicillin/streptomycin (Life
Technologies) and 1% L-glutamine (Life Technologies).
The IMR90 female fibroblast cell line was cultured with
10% fetal calf serum (PAA Laboratories Inc) and 1% L-
glutamine (Life Technologies). The HT1080XISTi trans-
genic cell line containing a DOX-inducible XIST was
cultured in Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with 10% fetal calf serum (PAA Laboratories
Inc), 1% penicillin/streptomycin (Life Technologies) and
1% L-glutamine (Life Technologies). CA1S cells were cul-
tured as described [53] on Matrigel (BD Biosciences) coated
6-well plates in mTeSR1 basal medium (STEMCELL)
supplemented with mTeSR1 5x supplement (STEMCELL)
and passaged using Accutase (STEMCELL). All lines were
cultured at 37°C.
PCR and quantitative PCR
PCR was performed with 100 ng of genomic DNA tem-
plate, 1U Taq polymerase, 0.2 mM dNTPs, 1.5 mM
MgCl2, 1X PCR buffer (all from Invitrogen) and 0.5 μM
of both forward and reverse primers. PCR was per-
formed using 30–40 cycles of [95°C for 30 s, 55°-60°C
for 30 s, 72°C for 1 min]. Quantitative PCR (qPCR) was
performed using the StepOnePlusTM Real-Time PCR
System (Applied Biosystems) and the qPCR reaction mix
was composed of 0.2 mM dNTP mix, 2.5 mM MgCl2,
1X HS reaction buffer, 1X EvaGreen dye (Biotum),
0.25 μM forward and reverse primer, and 0.8 U Maxima
Hot Start Taq (Fermentas) or AptaTaq Fast DNA poly-
merase (Roche) and cycling conditions were as follows:
95°C for 5 min, followed by 40 cycles of [95°C for 15 s,
60°C for 30 s, 72°C for 1 min]. Each sample and negative
control was assayed in triplicate.
RNA extraction and reverse transcription
RNA was extracted using Trizol (Invitrogen) following
the manufacturer’s instructions. RNA was treated using
the DNA-free kit (Ambion) to remove genomic DNAcontamination according to the manufacturer’s instruc-
tions and RNA concentrations were determined using a
spectrophotometer. Reverse transcription (RT) of RNA
was carried out using 2 μg of RNA, 1x first strand buffer
(Invitrogen), 0.01 mM Dithiothreitol (DTT) (Invitrogen),
0.125 mM dNTPs, 1 μL random hexamers, 1 μl RNase
Inhibitor (Fermentas) and 1 μL (1U) of Moloney Murine
Leukemia Virus reverse transcriptase (M-MLV) and water
was added to a total volume of 20 μL. Reactions without
RT were also carried to out to test for complete removal
of genomic DNA contamination. Reaction mixes were in-
cubated for 1 h at 42°C and heat inactivated by incubating
at 95°C for 5 min.
For strand-specific RT reactions 2 μg of RNA was
mixed with 0.50 μM dNTPs and 2 pmol of sense or anti-
sense gene specific primer with a T7 sequence tag on
the 5′ end of the primer and then heated to 70°C for
5 min. Following this incubation the tubes were placed
on ice for 1 min and then mixed with 1x first strand
buffer (Invitrogen), 0.005 DTT, 1 μL (1U) RNase Inhibi-
tor (Fermentas) and 1 μL (1U) Superscript III. Reactions
minus RT were also carried to out to test for complete
removal of genomic DNA contamination. Reaction mixes
were incubated for 1 h at 55°C and heat inactivated by
incubating at 95°C for 5 min.
5′ and 3′ rapid amplification of cDNA ends
5′ RACE was performed using the First Choice RLM-
RACE kit (Ambion) as per the manufacturer’s instruc-
tions. 5′ RACE cDNA was amplified using nested PCR
reactions (components as above) with 35 cycles each
and annealing temperatures of 57°C, for the outer PCR
reaction, and 59°C for the inner PCR reaction. 3′ RACE
was performed using the First Choice RLM-RACE kit
(Ambion) as per the manufacturer’s instructions. PCR
products from both 5′ and 3′ RACE were analyzed
using 2% gel electrophoresis and PCR products purified
with the QIAquickGel extraction kit (Qiagen) for
Sanger sequencing.
siRNA-mediated knockdown
Knockdown was performed according to the manufac-
turer’s instructions. Briefly, 100,000 cells were seeded
into each well of a 24 well tissue culture plate. After
24 hrs the cells were transfected with 2 μL of Dharmafect
4 transfection reagent (Thermo Scientific) and 0.05 μM of
siGenome SMARTpool siRNA (M-011796-02 for YY1)
and harvested after a further 72 hrs.
Chromatin immunoprecipitation
Briefly, 5,000,000 cells were crosslinked using with 1%
formaldehyde and lysed with cell lysis buffer (10 mM
Tris–HCl, pH 8, 10 mM NaCl, 3 mM MgCl2, 0.5% Igepal,
protease inhibitor). Nuclei were resuspended in nuclear
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pH 8, protease inhibitor) and sonicated for 10 min to a
chromatin range of 150 bp to 500 bp. NaCl was added to
the chromatin to a final concentration of 150 mM and
then diluted in ChIP dilution buffer (0.01% SDS, 1.1%
Triton X-100, 150 mM NaCl, 16.7 mM Tris–HCl pH 8).
1% chromatin was collected for input DNA and remaining
chromatin was incubated with either 10ug IgG antibody
(I8140; Sigma) or 10 ug YY1 antibody (sc-1703; Santa Cruz
Biotechnology, Inc.) overnight. Chromatin and antibody
was incubated with blocked protein A:G beads and then
washed with low-salt buffer (0.1% SDS, 1% Triton X-100,
2 mM EDTA, 20 mM EDTA, 20 mM Tris–HCl, pH 8,
150 mM NaCl), high salt buffer (0.1% SDS, 1%Triton
X-100, 2 mM EDTA, 20 mM Tris–HCl, pH 8, 500 mM
NaCl), LiCL buffer (0.25 M LiCl, 1% Igepal, 1% Deoxycho-
late, 1 mM EDTA, 10 mM Tris–HCl, pH 8) and TE buf-
fer (10 mM EDTA, 10 mM Tris–HCl, ph 8) and then
eluted with elution buffer (1% SDS, 0.1 M NaHC3).
Precipitated chromatin and input DNA were was uncross-
linked overnight in elution buffer and 0.192 M NaCl and
proteinase K and purified using QIAquick DNA purifica-
tion columns. Locus-specific enrichment was quantified
using qPCR.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
5.02. One-way ANOVA was used to test for significance
in DHS experiments between different concentrations of
DNase I.
FISH analysis
RNA FISH was carried out as described by [54]. An
XIST probe and human Cot-1 DNA (Invitrogen) probe
were fluorescently labelled by nick translation (Abbott
Molecular Inc.) using SpectrumGreen-UTP (Vysis) for
XIST and SpectrumRed-UTP (Vysis) for Cot-1. The XIST
probe used, HbC1a, covers a ~1.6 kb region of XIST in-
cluding most of the repeat A region. Briefly, cells grown
on glass coverslips were permeabilized in 0.5% Triton
X-100 for eight minutes and then fixed in 4% para-
formaldehyde (Electron Microscopy Sciences) for eight
minutes. Cells were hybridized overnight with 150 ng
XIST probe and 150 ng human Cot-1 DNA probe. Fol-
lowing a series of post-hybridization rinses, the co-
verslips were counterstained with DAPI and mounted
on glass slides with Vectashield (Vector Laboratories)
for imaging.
DNA methylation analysis by pyrosequencing
Three female cell lines (GM08399, GM05396 and
GM08134), two male cell lines (GM7057 and GM1200),
two Xa hybrids (t60-12 and AHA-11aB1) and four Xi
hybrids (t86-B1maz-1b, t75-, tHM-1A and tHM-34-2A)were each assessed for methylation using four pyrose-
quencing assays. Pyrosequencing was performed using a
Pyromark ID machine as previously outlined in Cotton
et al. [55]. Briefly, approximately 25 ng of bisulfite
converted DNA was PCRed along with 1X PCR Buf-
fer (Qiagen), 0.2 mM dNTPs, 0.025 U HotStart Taq DNA
Polymerase (Qiagen), 0.25 mM forward primer and
0.25 mM reverse primer (listed in Additional file 2:
Table S1). PCR cycling conditions were the same for
all four Pyrosequencing assays, 95°C for 15 min, 50 cycles
of 94°C for 30 s, 55°C for 30 s, 72°C for 60 s, followed by a
final step of 72°C for 10 min.
Additional files
Additional file 1: Figure S1. Transcription at the XIST locus in CA1S
male hES cells A) Schematic of XIST indicating primer positions (*) used
in RT-PCR. B) RT-PCR in CA1S cells at the XIST locus. C) Strand specific
RT-PCR to determine orientation of transcription.
Additional file 2: Table S1. Primers used in this manuscript.
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